title: Living donor liver transplantation: eliminating the wait for death in end-stage liver disease?
abstract: Adult-to-adult living donor liver transplantation (A2ALDLT), outside of Asia, remains an important yet underutilized gift of life. For patients with end-stage liver disease, A2ALDLT is a proven transplantation option, with lower waiting list mortality and suffering, and equivalent or better allograft and patient survival than deceased-donor liver transplantation (DDLT). The risks to living donors and the benefit to their recipients have been carefully defined with long-term level 1 and 2 evidence-based study. An overview of the development and practice of living donor liver transplant (LDLT), including donor and recipient surgical allograft innovation, is provided. The issues of recipient selection, outcomes and morbidity, including disease-variable study and challenges past and present are presented in comparison with DDLT cohorts, and future insights are described. Central to practice is the careful and concise review of donor evaluation and selection and donor outcome, morbidity, quality of life and present and future strategies for donor advocacy and growth of the technique.
authors.affiliation: Beth Israel Deaconess Medical Center Transplant Institute, 110 Francis Street, 7th Floor Boston, Massachusetts 02215 United States.
authors.forename: Robert A
authors.initials: RA
authors.lastname: Fisher
mesh_terms: D000075202:Contraindications; D017281:Cost of Illness; D046148:Donor Selection / Q000379:methods; D058625:End Stage Liver Disease / Q000601:surgery*; D006498:Hepatectomy / Q000379:methods; D006801:Humans; D007258:Informed Consent; D007348:Insurance, Health; D010535:Laparoscopy / Q000379:methods; D016031:Liver Transplantation / Q000379:methods*; D019520:Living Donors / Q000523:psychology / Q000600:supply & distribution*; D008603:Mental Health; D010808:Physical Examination / Q000379:methods; D011788:Quality of Life; D060053:Transplant Donor Site; D016896:Treatment Outcome